On the public citation graph
Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
0 signed · 392 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s00535-013-0783-4openalex-snapshot
Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats
inferredcites →https://doi.org/10.1007/s10157-013-0781-0openalex-snapshot
Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2010.08.064openalex-snapshot
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
inferredcites →https://doi.org/10.1016/j.cmet.2006.01.004openalex-snapshot
The biology of incretin hormones
inferredcites →https://doi.org/10.1016/j.febslet.2009.12.053openalex-snapshot
High glucose down‐regulates miR‐29a to increase collagen IV production in HK‐2 cells
inferredcites →https://doi.org/10.1016/j.lfs.2007.04.040openalex-snapshot
Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin
inferredcites →https://doi.org/10.1016/j.yjmcc.2011.08.001openalex-snapshot
Effects of DPP-4 inhibition on cardiac metabolism and function in mice
inferredcites →https://doi.org/10.1016/s0046-8177(70)80060-0openalex-snapshot
Structural-functional correlations in renal disease
inferredcites →https://doi.org/10.1016/s0046-8177(70)80061-2openalex-snapshot
Structural-functional correlations in renal disease
inferredcites →https://doi.org/10.1016/s0140-6736(68)90589-8openalex-snapshot
RELATIONSHIP BETWEEN RENAL FUNCTION AND HISTOLOGICAL CHANGES FOUND IN RENAL-BIOPSY SPECIMENS FROM PATIENTS WITH PERSISTENT GLOMERULAR NEPHRITIS
inferredcites →https://doi.org/10.1016/s0167-0115(99)00089-0openalex-snapshot
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
inferredcites →https://doi.org/10.1016/s0272-6386(12)80312-xopenalex-snapshot
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
inferredcites →https://doi.org/10.1038/hr.2012.159openalex-snapshot
Pathophysiology of the aging kidney and therapeutic interventions
inferredcites →https://doi.org/10.1038/nm.2991openalex-snapshot
Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
inferredcites →https://doi.org/10.1038/nm.3218openalex-snapshot
Origin and function of myofibroblasts in kidney fibrosis
inferredcites →https://doi.org/10.1038/nm1613openalex-snapshot
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
inferredcites →https://doi.org/10.1038/onc.2008.402openalex-snapshot
Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation
inferredcites →https://doi.org/10.1038/sj.bjc.6604662openalex-snapshot
The role of endothelial-to-mesenchymal transition in cancer progression
inferredcites →https://doi.org/10.1073/pnas.0805038105openalex-snapshot
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
inferredcites →https://doi.org/10.1074/jbc.m202770200openalex-snapshot
Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase Complex
inferredcites →https://doi.org/10.1111/1755-5922.12005openalex-snapshot
DPP‐4 Inhibition Attenuates Cardiac Dysfunction and Adverse Remodeling Following Myocardial Infarction in Rats with Experimental Diabetes
inferredcites →https://doi.org/10.1111/j.1463-1326.2010.01212.xopenalex-snapshot
Pharmacokinetics of dipeptidylpeptidase‐4 inhibitors
inferredcites →https://doi.org/10.1124/dmd.109.031476openalex-snapshot
The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans
inferredcites →https://doi.org/10.1124/jpet.111.186866openalex-snapshot
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
inferredcites →https://doi.org/10.1152/ajpheart.00454.2012openalex-snapshot
Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice
inferredcites →https://doi.org/10.1152/ajpregu.00569.2006openalex-snapshot
Des-serine-proline brain natriuretic peptide 3–32 in cardiorenal regulation
inferredcites →https://doi.org/10.1155/2011/279530openalex-snapshot
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
inferredcites →https://doi.org/10.1161/hypertensionaha.109.144428openalex-snapshot
Renal Medullary MicroRNAs in Dahl Salt-Sensitive Rats
inferredcites →https://doi.org/10.1165/rcmb.2010-0323ocopenalex-snapshot
miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
inferredcites →https://doi.org/10.1172/jci40594openalex-snapshot
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
inferredcites →https://doi.org/10.1186/1755-1536-5-13openalex-snapshot
Diabetic angiopathy and angiogenic defects
inferredcites →https://doi.org/10.1371/journal.pone.0027861openalex-snapshot
Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
inferredcites →https://doi.org/10.1371/journal.pone.0038744openalex-snapshot
Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
inferredcites →https://doi.org/10.2337/db06-1226openalex-snapshot
Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors
inferredcites →https://doi.org/10.2337/dc11-s223openalex-snapshot
Therapy in the Early Stage: Incretins
inferredcites →https://doi.org/10.2337/dc13-0323openalex-snapshot
Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
inferredcites →https://doi.org/10.3389/fendo.2013.00007openalex-snapshot
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4869098openalex-extracted
MiR-200b Induces ZEB1-Mediated ST14/Matriptase Upregulation: Implications for Podocyte Function in Diabetic Kidney Disease
inferred← citeshttps://doi.org/10.1002/9781119105954.ch24openalex-snapshot
Secondary Diseases of the Kidney
inferred← citeshttps://doi.org/10.1002/9781119790419.ch17openalex-snapshot
THE ROLE OF OXIDATIVE STRESS IN CHRONIC KIDNEY DISEASE (CKD)
inferred← citeshttps://doi.org/10.1002/9781119790419.ch18openalex-snapshot
BIOMARKERS OF OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
inferred← citeshttps://doi.org/10.1002/9783527678433.ch7openalex-snapshot
Discovery of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/adtp.202500304openalex-snapshot
Extracellular Vesicles: Biology, Intercellular Communication and Therapeutic Potential in Diabetes
inferred← citeshttps://doi.org/10.1002/jcb.29896openalex-snapshot
The role of miR‐29 family in disease
inferred← citeshttps://doi.org/10.1002/jcp.27503openalex-snapshot
Narrative review of the effects of antidiabetic drugs on albuminuria
inferred← citeshttps://doi.org/10.1002/jcp.29817openalex-snapshot
miR‐448‐3p alleviates diabetic vascular dysfunction by inhibiting endothelial–mesenchymal transition through DPP‐4 dysregulation
inferred← citeshttps://doi.org/10.1002/jev2.12304openalex-snapshot
An in vitro approach to understand contribution of kidney cells to human urinary extracellular vesicles
inferred← citeshttps://doi.org/10.1002/med.21513openalex-snapshot
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
inferred← citeshttps://doi.org/10.1002/sim.10118openalex-snapshot
Robust inference for causal mediation analysis of recurrent event data
inferred← citeshttps://doi.org/10.1007/978-3-319-08982-9_6openalex-snapshot
Future and emerging therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-51436-9_13openalex-snapshot
Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis
inferred← citeshttps://doi.org/10.1007/978-981-13-8871-2_4openalex-snapshot
A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1007/s00210-023-02667-3openalex-snapshot
RETRACTED ARTICLE: Pylorus ligation-induced hyperacidity: synergistic prophylactic effects of linagliptin and L-arginine via up-regulation of EP4 receptor subtype and improvement of vascular endothelial damage
inferred← citeshttps://doi.org/10.1007/s00424-024-02915-2openalex-snapshot
Renal and cardiac effects of the PDE9 inhibitor BAY 73–6691 in 5/6 nephrectomized rats
inferred← citeshttps://doi.org/10.1007/s10157-017-1521-7openalex-snapshot
The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial
inferred← citeshttps://doi.org/10.1007/s10557-017-6755-9openalex-snapshot
Diabetic Nephropathy: a Tangled Web to Unweave
inferred← citeshttps://doi.org/10.1007/s11010-021-04349-1openalex-snapshot
Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition
inferred← citeshttps://doi.org/10.1007/s11033-025-11425-yopenalex-snapshot
Endothelial-Mesenchymal transition in cerebrovascular diseases: molecular mechanisms and promising pharmacological strategies
inferred← citeshttps://doi.org/10.1007/s11892-018-0991-7openalex-snapshot
Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes
inferred← citeshttps://doi.org/10.1007/s12272-016-0813-xopenalex-snapshot
DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
inferred← citeshttps://doi.org/10.1007/s12272-019-01130-3openalex-snapshot
Recent advances in the pathogenesis of microvascular complications in diabetes
inferred← citeshttps://doi.org/10.1007/s12325-022-02223-0openalex-snapshot
A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches
inferred← citeshttps://doi.org/10.1007/s13318-019-00570-yopenalex-snapshot
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
inferred← citeshttps://doi.org/10.1007/s13340-018-0376-9openalex-snapshot
Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study
inferred← citeshttps://doi.org/10.1007/s40265-014-0308-3openalex-snapshot
Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/s43032-022-01064-0openalex-snapshot
Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-816413-6.00026-5openalex-snapshot
Role of mesenchymal stem cells in diabetic wound healing
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114045openalex-snapshot
MicroRNAs and their delivery in diabetic fibrosis
inferred← citeshttps://doi.org/10.1016/j.bbadis.2025.167683openalex-snapshot
Epithelium-derived exosomal dipeptidyl peptidase-4 involved in arecoline-induced oral submucous fibrosis
inferred← citeshttps://doi.org/10.1016/j.bbagen.2017.11.012openalex-snapshot
Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice
inferred← citeshttps://doi.org/10.1016/j.bbalip.2020.158755openalex-snapshot
Mitigation of renal inflammation and endoplasmic reticulum stress by vildagliptin and statins in high-fat high-fructose diet-induced insulin resistance and renal injury in rats
inferred← citeshttps://doi.org/10.1016/j.bbrc.2016.01.109openalex-snapshot
Renoprotective effect of DPP-4 inhibitors against free fatty acid-bound albumin-induced renal proximal tubular cell injury
inferred← citeshttps://doi.org/10.1016/j.bbrc.2016.01.154openalex-snapshot
Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115032openalex-snapshot
Current findings on the efficacy of incretin-based drugs for diabetic kidney disease: A narrative review
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118497openalex-snapshot
Empagliflozin reduces left ventricular mass increase and improves cardiomyocyte hypertrophy after 5/6 nephrectomy
inferred← citeshttps://doi.org/10.1016/j.cca.2019.08.028openalex-snapshot
The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases
inferred← citeshttps://doi.org/10.1016/j.diabet.2020.06.005openalex-snapshot
Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells
inferred← citeshttps://doi.org/10.1016/j.diabres.2021.108691openalex-snapshot
CD161a-positive natural killer (NK) cells and α-smooth muscle actin-positive myofibroblasts were upregulated by extrarenal DPP4 in a rat model of acute renal rejection
inferred← citeshttps://doi.org/10.1016/j.diabres.2026.113288openalex-snapshot
DPP-4 inhibitors in current diabetes care: their foundational role in treating to target
inferred← citeshttps://doi.org/10.1016/j.dsx.2018.11.001openalex-snapshot
Serum adipocytokines are associated with microalbuminuria in patients with type 1 diabetes and incipient chronic complications
inferred← citeshttps://doi.org/10.1016/j.ejcb.2018.07.005openalex-snapshot
EndMT: A promising and controversial field
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.04.023openalex-snapshot
Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.04.055openalex-snapshot
Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.ejphar.2016.04.005openalex-snapshot
Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats
inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.173037openalex-snapshot
The protective role of DPP4 inhibitors in atherosclerosis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177896openalex-snapshot
Lithospermic acid improves diabetic kidney fibrosis by regulating Piezo1/TGF-β1/Smad signaling pathway
inferred← citeshttps://doi.org/10.1016/j.etap.2017.02.008openalex-snapshot
RETRACTED: Ameliorative potential of linagliptin and/or calcipotriol onbleomycin-induced lung fibrosis: In vivo and in vitro study
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102390openalex-snapshot
Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys
inferred← citeshttps://doi.org/10.1016/j.jacbts.2018.01.005openalex-snapshot
Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation
inferred← citeshttps://doi.org/10.1016/j.jacbts.2021.04.006openalex-snapshot
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis
inferred← citeshttps://doi.org/10.1016/j.jare.2017.04.004openalex-snapshot
Diabetic nephropathy: Time to withhold development and progression - A review
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.101725openalex-snapshot
TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial–mesenchymal transition in diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.jdiacomp.2016.08.022openalex-snapshot
Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes
inferred← citeshttps://doi.org/10.1016/j.jdiacomp.2018.04.011openalex-snapshot
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
inferred← citeshttps://doi.org/10.1016/j.jgr.2019.01.003openalex-snapshot
Ginsenoside Rg3 protects against iE-DAP–induced endothelial-to-mesenchymal transition by regulating the miR-139-5p–NF-κB axis
inferred← citeshttps://doi.org/10.1016/j.jphs.2017.10.003openalex-snapshot
The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo
inferred← citeshttps://doi.org/10.1016/j.jphs.2017.11.006openalex-snapshot
The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure
inferred← citeshttps://doi.org/10.1016/j.kint.2016.01.016openalex-snapshot
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy
inferred← citeshttps://doi.org/10.1016/j.kint.2016.06.012openalex-snapshot
Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2016.06.018openalex-snapshot
Exogenous kallikrein protects against diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2016.06.036openalex-snapshot
MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells
inferred← citeshttps://doi.org/10.1016/j.kint.2019.01.010openalex-snapshot
Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.01.044openalex-snapshot
Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120757openalex-snapshot
Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure
inferred← citeshttps://doi.org/10.1016/j.lpm.2023.104178openalex-snapshot
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years
inferred← citeshttps://doi.org/10.1016/j.mce.2018.06.005openalex-snapshot
MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis
inferred← citeshttps://doi.org/10.1016/j.metabol.2017.07.007openalex-snapshot
Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model
inferred← citeshttps://doi.org/10.1016/j.metabol.2018.07.001openalex-snapshot
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment
inferred← citeshttps://doi.org/10.1016/j.metop.2023.100236openalex-snapshot
Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.metop.2023.100240openalex-snapshot
Predictive significance of glomerular insulin receptor substrate-1 in patients with diabetic kidney disease
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2019.05.007openalex-snapshot
DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?
inferred← citeshttps://doi.org/10.1016/j.phrs.2019.104391openalex-snapshot
More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104662openalex-snapshot
Incretins and microRNAs: Interactions and physiological relevance
inferred← citeshttps://doi.org/10.1016/j.tice.2024.102375openalex-snapshot
A cross talk study on sitagliptin mediated reclamation on TGF β signalling, DPP 4, miR-29a and miR-24 expression in PCOS rats fed with high fat-high fructose diet
inferred← citeshttps://doi.org/10.1016/j.trre.2015.01.001openalex-snapshot
Antidiabetic therapy in post kidney transplantation diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.xkme.2021.07.007openalex-snapshot
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
inferred← citeshttps://doi.org/10.1016/j.yjmcc.2026.05.009openalex-snapshot
The mechanistic of DCBLD2 in inhibiting TGF-β induced endothelial-mesenchymal transition in calcific aortic valve disease
inferred← citeshttps://doi.org/10.1016/j.ymthe.2020.08.017openalex-snapshot
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1038/ki.2015.103openalex-snapshot
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
inferred← citeshttps://doi.org/10.1038/ki.2015.175openalex-snapshot
Evidence for antifibrotic incretin-independent effects of the DPP-4 inhibitor linagliptin
inferred← citeshttps://doi.org/10.1038/labinvest.2015.35openalex-snapshot
Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis
inferred← citeshttps://doi.org/10.1038/labinvest.2016.34openalex-snapshot
DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury
inferred← citeshttps://doi.org/10.1038/nrneph.2017.123openalex-snapshot
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
inferred← citeshttps://doi.org/10.1038/s12276-019-0268-5openalex-snapshot
Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells
inferred← citeshttps://doi.org/10.1038/s12276-020-0439-4openalex-snapshot
Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage
inferred← citeshttps://doi.org/10.1038/s41419-018-1057-0openalex-snapshot
SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis
inferred← citeshttps://doi.org/10.1038/s41420-026-03078-yopenalex-snapshot
AMPK is dispensable for physiological podocyte and glomerular functions but prevents glomerular fibrosis in experimental diabetes
inferred← citeshttps://doi.org/10.1038/s41467-021-22617-yopenalex-snapshot
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
inferred← citeshttps://doi.org/10.1038/s41581-018-0098-zopenalex-snapshot
Endothelium structure and function in kidney health and disease
inferred← citeshttps://doi.org/10.1038/s41581-020-00367-2openalex-snapshot
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
inferred← citeshttps://doi.org/10.1038/s41598-017-11487-4openalex-snapshot
MicroRNA Profiling Reveals Distinct Profiles for Tissue-Derived and Cultured Endothelial Cells
inferred← citeshttps://doi.org/10.1038/s41598-019-43730-5openalex-snapshot
Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice
inferred← citeshttps://doi.org/10.1038/s41598-020-60336-4openalex-snapshot
Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy
inferred← citeshttps://doi.org/10.1038/s41598-020-62579-7openalex-snapshot
Linagliptin affects IRS1/Akt signaling and prevents high glucose-induced apoptosis in podocytes
inferred← citeshttps://doi.org/10.1038/s41598-025-06395-xopenalex-snapshot
Association of urinary dipeptidyl peptidase 4 activity with clinical outcomes in people with chronic kidney disease
inferred← citeshttps://doi.org/10.1038/s41598-025-95952-5openalex-snapshot
MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation
inferred← citeshttps://doi.org/10.1038/s44222-023-00144-3openalex-snapshot
Modelling and targeting mechanical forces in organ fibrosis
inferred← citeshttps://doi.org/10.1038/srep20304openalex-snapshot
ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1038/srep29884openalex-snapshot
Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
inferred← citeshttps://doi.org/10.1042/cs20180031openalex-snapshot
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
inferred← citeshttps://doi.org/10.1053/j.ackd.2017.12.005openalex-snapshot
Acute Kidney Injury and Progression of Diabetic Kidney Disease
inferred← citeshttps://doi.org/10.1053/j.ajkd.2015.03.024openalex-snapshot
Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1055/s-0041-1741109openalex-snapshot
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
inferred← citeshttps://doi.org/10.1080/01480545.2026.2711683openalex-snapshot
Linagliptin attenuates cisplatin-induced cardiotoxicity in rats via modulation of the SIRT1/AMPK/Nrf2 signaling pathway
inferred← citeshttps://doi.org/10.1080/0886022x.2022.2039194openalex-snapshot
MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway
inferred← citeshttps://doi.org/10.1080/08923973.2026.2741565openalex-snapshot
Vildagliptin attenuates thioacetamide-induced hepatic fibrosis in rats: associations with AMPK/SIRT1/Nrf2 and STAT3/TGF-β1 signaling
inferred← citeshttps://doi.org/10.1080/13543784.2019.1592156openalex-snapshot
Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease
inferred← citeshttps://doi.org/10.1080/13813455.2021.2023580openalex-snapshot
Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease
inferred← citeshttps://doi.org/10.1080/14656566.2022.2054699openalex-snapshot
Recent advances in the pharmacotherapeutic management of diabetic kidney disease
inferred← citeshttps://doi.org/10.1080/14728222.2017.1370455openalex-snapshot
Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
inferred← citeshttps://doi.org/10.1080/14728222.2022.2133698openalex-snapshot
Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules
inferred← citeshttps://doi.org/10.1080/1744666x.2025.2521086openalex-snapshot
Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review
inferred← citeshttps://doi.org/10.1080/17460441.2021.1832077openalex-snapshot
Recent advances in drug discovery for diabetic kidney disease
inferred← citeshttps://doi.org/10.1080/17476348.2020.1795832openalex-snapshot
Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis
inferred← citeshttps://doi.org/10.1080/19768354.2023.2244549openalex-snapshot
Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition
inferred← citeshttps://doi.org/10.1089/ars.2016.6953openalex-snapshot
Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis
inferred← citeshttps://doi.org/10.1089/scd.2023.0262openalex-snapshot
Extracellular Vesicles Derived from Type 2 Diabetic Mesenchymal Stem Cells Induce Endothelial Mesenchymal Transition under High Glucose Conditions Through the TGFβ/Smad3 Signaling Pathway
inferred← citeshttps://doi.org/10.1093/ckj/sfaa225openalex-snapshot
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
inferred← citeshttps://doi.org/10.1093/cvr/cvz211openalex-snapshot
Non-coding RNA in endothelial-to-mesenchymal transition
inferred← citeshttps://doi.org/10.1093/ehjqcco/qcac040openalex-snapshot
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor
inferred← citeshttps://doi.org/10.1093/ndt/gfv093openalex-snapshot
Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents
inferred← citeshttps://doi.org/10.1096/fj.202401069rrropenalex-snapshot
miR ‐29 inhibits endothelial‐to‐mesenchymal transition in pulmonary hypertension of the newborn by regulating LRP6
inferred← citeshttps://doi.org/10.1097/hjh.0000000000000328openalex-snapshot
Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy
inferred← citeshttps://doi.org/10.1097/hjh.0000000000000776openalex-snapshot
Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients
inferred← citeshttps://doi.org/10.1097/mnh.0000000000000080openalex-snapshot
Dipeptidyl peptidase-4 inhibitors in progressive kidney disease
inferred← citeshttps://doi.org/10.1097/mnh.0000000000000234openalex-snapshot
New strategies to tackle diabetic kidney disease
inferred← citeshttps://doi.org/10.1097/mnh.0000000000000291openalex-snapshot
Dipeptidyl peptidase-4 inhibition and renoprotection
inferred← citeshttps://doi.org/10.1097/prs.0000000000006904openalex-snapshot
Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan
inferred← citeshttps://doi.org/10.1097/tp.0000000000002589openalex-snapshot
Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction
inferred← citeshttps://doi.org/10.1097/xce.0000000000000088openalex-snapshot
Extrapancreatic contribution to glucose regulation by dipeptidyl peptidase 4 inhibition
inferred← citeshttps://doi.org/10.1101/2025.05.08.652142openalex-snapshot
Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney disease
inferred← citeshttps://doi.org/10.1111/1440-1681.13644openalex-snapshot
STAT5A modulated EndMT via upregulation of ELTD1 expression in diabetic nephropathy
inferred← citeshttps://doi.org/10.1111/1753-0407.12521openalex-snapshot
Macro‐ and microvascular endothelial dysfunction in diabetes
inferred← citeshttps://doi.org/10.1111/apha.14038openalex-snapshot
Endothelial cell plasticity in kidney fibrosis and disease
inferred← citeshttps://doi.org/10.1111/bcpt.14103openalex-snapshot
sGC stimulator (BAY 41‐8543) combined with PDE9 inhibitor (BAY 73‐6691) reduces renal fibrosis in 5/6 nephrectomized rats
inferred← citeshttps://doi.org/10.1111/bph.15087openalex-snapshot
Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease
inferred← citeshttps://doi.org/10.1111/bph.15320openalex-snapshot
The DPP4 inhibitor linagliptin ameliorated renal injury and accelerated resolution in a rat model of crescentic nephritis
inferred← citeshttps://doi.org/10.1111/bph.15967openalex-snapshot
Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis
inferred← citeshttps://doi.org/10.1111/dom.12863openalex-snapshot
Efficacy, safety and albuminuria‐reducing effect of gemigliptin in K orean type 2 diabetes patients with moderate to severe renal impairment: A 12‐week, double‐blind randomized study (the GUARD S tudy)
inferred← citeshttps://doi.org/10.1111/dom.13041openalex-snapshot
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA ‐ T2D trial
inferred← citeshttps://doi.org/10.1111/dom.13969openalex-snapshot
Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
inferred← citeshttps://doi.org/10.1111/exd.13800openalex-snapshot
Linagliptin inhibits high glucose‐induced transdifferentiation of hypertrophic scar‐derived fibroblasts to myofibroblasts via IGF /Akt/ mTOR signalling pathway
inferred← citeshttps://doi.org/10.1111/fcp.12736openalex-snapshot
Sitagliptin's renoprotective effect in a diabetic nephropathy model in rats: The potential role of PI3K/AKT pathway
inferred← citeshttps://doi.org/10.1111/jcmm.18336openalex-snapshot
Sirt7/ HIC1 complex participates in hyperglycaemia‐mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory
inferred← citeshttps://doi.org/10.1111/jdi.12317openalex-snapshot
Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
inferred← citeshttps://doi.org/10.1111/jdi.12380openalex-snapshot
Renoprotective effects of incretin‐based drugs: A novel pleiotropic effect of dipeptidyl peptidase‐4 inhibitor
inferred← citeshttps://doi.org/10.1111/jdi.12917openalex-snapshot
Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease
inferred← citeshttps://doi.org/10.1111/jdi.13219openalex-snapshot
N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects
inferred← citeshttps://doi.org/10.1111/jdi.13311openalex-snapshot
CD‐1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis
inferred← citeshttps://doi.org/10.1111/jdi.14017openalex-snapshot
Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis
inferred← citeshttps://doi.org/10.1111/jdi.70454openalex-snapshot
Linagliptin increases the expression of LRP2 independent of Nrf2 in streptozotocin‐induced diabetic mice
inferred← citeshttps://doi.org/10.1111/jpi.12666openalex-snapshot
Melatonin ameliorates aortic valve calcification via the regulation of circular RNA CircRIC3/miR‐204‐5p/DPP4 signaling in valvular interstitial cells
inferred← citeshttps://doi.org/10.1111/nyas.12758openalex-snapshot
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
inferred← citeshttps://doi.org/10.11213/tonyobyo.59.703openalex-snapshot
内皮細胞dipeptidyl Peptidase-4が演じる病理学的意義と腎線維化
inferred← citeshttps://doi.org/10.11213/tonyobyo.60.540openalex-snapshot
75歳以上の高齢2型糖尿病患者におけるリナグリプチンの効果と肝腎機能,脂質代謝への影響―75歳未満患者との比較及び腎機能低下例での検討―
inferred← citeshttps://doi.org/10.1124/dmd.116.073866openalex-snapshot
Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo
inferred← citeshttps://doi.org/10.1126/sciadv.adn6068openalex-snapshot
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
inferred← citeshttps://doi.org/10.1134/s0026893323030111openalex-snapshot
Molecular and Cellular Aspects of the Endothelial–Mesenchymal Transition in Cardiovascular Diseases
inferred← citeshttps://doi.org/10.1136/bmjdrc-2016-000227openalex-snapshot
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
inferred← citeshttps://doi.org/10.1136/bmjdrc-2017-000391openalex-snapshot
Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
inferred← citeshttps://doi.org/10.1139/cjpp-2020-0049openalex-snapshot
Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice
inferred← citeshttps://doi.org/10.1139/cjpp-2021-0265openalex-snapshot
Downregulation of acylglycerol kinase suppresses high-glucose-induced endothelial-mesenchymal transition in human retinal microvascular endothelial cells through regulating the LPAR1/TGF-β/Notch signaling pathway
inferred← citeshttps://doi.org/10.1152/ajpcell.00528.2022openalex-snapshot
Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system
inferred← citeshttps://doi.org/10.1152/ajpcell.00734.2023openalex-snapshot
Bidirectional relation between dipeptidyl peptidase 4 and angiotensin II type I receptor signaling
inferred← citeshttps://doi.org/10.1152/ajpregu.00270.2017openalex-snapshot
Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice
inferred← citeshttps://doi.org/10.1152/ajprenal.00316.2016openalex-snapshot
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4
inferred← citeshttps://doi.org/10.1152/ajprenal.00387.2015openalex-snapshot
Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases
inferred← citeshttps://doi.org/10.1152/ajprenal.00565.2020openalex-snapshot
DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice
inferred← citeshttps://doi.org/10.1152/physiolgenomics.00082.2016openalex-snapshot
Serum response factor induces endothelial-mesenchymal transition in glomerular endothelial cells to aggravate proteinuria in diabetic nephropathy
inferred← citeshttps://doi.org/10.1152/physrev.00021.2018openalex-snapshot
Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
inferred← citeshttps://doi.org/10.1155/2014/368703openalex-snapshot
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
inferred← citeshttps://doi.org/10.1155/2016/1379274openalex-snapshot
Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
inferred← citeshttps://doi.org/10.1155/2016/6962801openalex-snapshot
Endothelial‐Mesenchymal Transition in Regenerative Medicine
inferred← citeshttps://doi.org/10.1155/2016/9172157openalex-snapshot
Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
inferred← citeshttps://doi.org/10.1155/2016/9521629openalex-snapshot
Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1155/2018/1864107openalex-snapshot
Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats
inferred← citeshttps://doi.org/10.1155/2018/6872635openalex-snapshot
Circulating MicroRNAs in Elderly Type 2 Diabetic Patients
inferred← citeshttps://doi.org/10.1155/2018/6890501openalex-snapshot
MicroRNA and Microvascular Complications of Diabetes
inferred← citeshttps://doi.org/10.1155/2021/2182225openalex-snapshot
Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes
inferred← citeshttps://doi.org/10.1155/2021/8163153openalex-snapshot
Renoprotective Effects of Incretin‐Based Therapy in Diabetes Mellitus
inferred← citeshttps://doi.org/10.1159/000455874openalex-snapshot
Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1159/000490688openalex-snapshot
Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
inferred← citeshttps://doi.org/10.1159/000493380openalex-snapshot
Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy
inferred← citeshttps://doi.org/10.1159/000495517openalex-snapshot
Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats
inferred← citeshttps://doi.org/10.11606/d.5.2018.tde-16022018-113739openalex-snapshot
A inibição da dipeptidil peptidase IV reduz os níveis de angiotensina II e atenua o remodelamento e a disfunção cardíaca em ratos com doença renal crônica
inferred← citeshttps://doi.org/10.11606/t.5.2019.tde-08112019-163309openalex-snapshot
Efeito combinado da vildagliptina e do valsartan no tratamento da insuficiência cardíaca em ratos
inferred← citeshttps://doi.org/10.1161/atvbaha.119.312826openalex-snapshot
Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
inferred← citeshttps://doi.org/10.1161/atvbaha.121.313788openalex-snapshot
Endothelial-Mesenchymal Transition in Cardiovascular Disease
inferred← citeshttps://doi.org/10.1161/atvbaha.125.323824openalex-snapshot
ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease
inferred← citeshttps://doi.org/10.1161/circresaha.116.305665openalex-snapshot
DPP4 in Cardiometabolic Disease
inferred← citeshttps://doi.org/10.1161/hypertensionaha.120.15587openalex-snapshot
Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice
inferred← citeshttps://doi.org/10.1161/jaha.120.019437openalex-snapshot
Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus
inferred← citeshttps://doi.org/10.1167/iovs.64.10.2openalex-snapshot
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
inferred← citeshttps://doi.org/10.1172/jci.insight.129034openalex-snapshot
Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules
inferred← citeshttps://doi.org/10.1177/1479164115579002openalex-snapshot
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D ™ trial
showing the first 200 of 354 · page through all 354
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.